Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Assessing Fluid Status of Peritoneal Dialysis Patients With Assistance of Lung Ultrasound
NCT04176627 · View on ClinicalTrials.gov ↗
Study Summary
* As studied previously, lung congestion is very prevalent however usually asymptomatic in dialysis patients. Fluid overload is associated with hospitalizations, worse cardiovascular outcomes and mortality in PD patients. * The clinical exam is the only tool used currently to monitor volume status of PD patients, and has been found to have poor sensitivity and specificity for lung congestion compared to lung ultrasound. In current practice, patients are seen and examined monthly at their home dialysis units by the nurses. The nephrologist separately examines the patient monthly, possibly days to weeks after the nurse visit, and potentially only quarterly with the use of telehealth visits. * Lung ultrasound is a relatively simple and cheap tool to assess for lung congestion, with little inter-operator variability and good reproducibility. * There are limited studies of lung ultrasound in peritoneal dialysis, and none in the United States. Lung ultrasound may be useful as an objective measure of lung congestion in patients without signs or symptoms of fluid overload. Aims of this study * This study aims to determine the prevalence of subclinical fluid overload in peritoneal dialysis patients. * The investigators aim to determine the added benefit of lung ultrasound to standard clinical practice of fluid management in PD patients. * The investigators aim to assess the association of patient characteristics with lung congestion. * The investigators also aim to assess the agreement between nurse physical exam and lung ultrasound for fluid overload.
Conditions Studied
Interventions
- DEVICE Lung ultrasound
Study Locations (16)
California
- WellBound Daly City — Daly City
- Satellite WellBound Emeryville — Emeryville
- Satellite WellBound Fremont — Fremont
- Satellite WellBound Milpitas — Milpitas
- WellBound Modesto — Modesto
- WellBound North Modesto — Modesto
- Satellite WellBound Mountain View — Mountain View
- WellBound Sacramento — Sacramento
- WellBound San Francisco — San Francisco
- Satellite WellBound San Jose — San Jose
- WellBound San Leandro — San Leandro
- Satellite WellBound San Mateo — San Mateo
- Wellbound Santa Cruz — Santa Cruz
- WellBound Santa Rosa — Santa Rosa
- WellBound Stockton — Stockton
- WellBound Vallejo — Vallejo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2019-12-02 |
| Est. Completion | 2020-06-30 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04176627
The ClinicalTrials.gov registry entry for NCT04176627 describes a study currently listed as completed. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Satellite Healthcare, which has 2 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Peritoneal Dialysis Complication appearing as the primary indexed condition, and to 1 intervention — of which Lung ultrasound is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT04176627 reports 16 study locations spanning 1 distinct geographic area — top geographies include California. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT04176627 about?
NCT04176627 is a clinical study titled "Assessing Fluid Status of Peritoneal Dialysis Patients With Assistance of Lung Ultrasound". * As studied previously, lung congestion is very prevalent however usually asymptomatic in dialysis patients. Fluid overload is associated with hospitalizations, worse cardiovascular outcomes and mortality in PD patients. * The clinical exam is the only tool used currently to monitor volume status o...
What is the current status of trial NCT04176627?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2019-12-02. Estimated completion is 2020-06-30.
What conditions does trial NCT04176627 study?
This clinical trial studies the following conditions: Peritoneal Dialysis Complication, Fluid Overload Pulmonary Edema. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT04176627?
The interventions under investigation include: Lung ultrasound (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT04176627?
This trial is sponsored by Satellite Healthcare, which has 2 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT04176627 being conducted?
This trial has 16 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.